semaglutide's weight loss effects traced to specific brain cells Why do some patients plateau on semaglutide while others keep losing? New research it a single signaling pathway inside the brain, and found a potential way to override it. Swipe Weight loss linked to nerve

Antiamyloid therapies have recently changed the treatment landscape

Projected global sales by 2030 for GLP-1 could increase by 2.6x

Semaglutide, the active ingredient in brand medicines like Ozempic and Wegovy, could raise the risk of a relatively rare eye disease that is a leading cause of vision loss, according to a retrospective study.

Most incretin-based therapies drive impressive fat loss, but at a cost: significant lean mass depletion worse metabolic health higher long-term risk, especially in Diabetes This graphic highlights a two-pronged approach: Semaglutide reduces appetite & fat mass Bimagrumab blocks ActRIIA/B signalling, preventing muscle atrophy Clinical data (BELIEVE trial) shows that combining the two: enhances fat loss preserves or increases lean mass improves overall body composition, not just the number on the scale In a season where weight gain is almost guaranteed, the future of obesity treatment isnt eat less and lose everything. Its lose fat while building muscle

12 month program to help employees manage their weight, now with GLP-1 support

Millions with Crohn's disease struggle with weight management while protecting their gut health